Growing Body of Evidence Supports Use of HIPEC in Ovarian Cancer
September 18th 2019A large pool of evidence exists to support the use of HIPEC in ovarian cancer, and hyperthermic and other novel intraperitoneal chemotherapies should continue to be incorporated into novel clinical trial designs.
Read More